Reports
Global Allergy Diagnostics and Therapeutics Market: By Product: Instruments, Consumables, Services; By Allergen Type: Food, Inhaled, Drug, Others; By End Use; By Diagnostic Tests; By Drug Class; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Allergy Diagnostics & Therapeutics Market Outlook
The global allergy diagnostics & therapeutics market was estimated at USD 38.68 billion in 2022 and is projected to increase further over the forecast period of 2023-2028 at a CAGR of 6.50%.
Rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, are anticipated to drive the industry growth of the allergy diagnostics & therapeutics in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
The allergy diagnostics & therapeutics market can be divided on the basis of segments like product, allergen type, end-use, diagnostic tests, and drug class. The industry can be broadly categorised on the basis of product into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
- Instruments
- Consumables
- Services
The industry can be categorised on the basis of allergen type into:
- Food
- Inhaled
- Drug
- Others
The industry can be divided based on end-uses into:
- Diagnostics labs
- Hospitals
- Academic Research Institutes
The industry can be divided on the basis of diagnostic tests as:
- In-Vivo
- Skin Prick Test
- Intradermal
- Patch Test
- In-Vitro
The industry can be segmented based on drug class as:
- Antihistamines
- Decongestants
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anticholinergics
- Immunomodulators
- Autoinjectable Epinephrine
- Immunotherapy
The EMR report looks into the regional markets of allergy diagnostics & therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The growth of the allergy diagnostics & therapeutics industry is expected to be driven by a number of factors, such as the high incidence and high economic burden of allergic diseases, increased healthcare spending, and increased access to medical insurance in the United States. Within allergy testing, factors such as widespread availability and high consumption of assay kits are expected to drive the development of this segment in the following years. The category of inhaled allergens is projected to represent the largest share of the market for allergy diagnostics in the forecast period. Increasing environmental pollution is one of the main factors driving the market growth. Growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance are the key factors accelerating the market growth.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global allergy diagnostics & therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- GlaxoSmithKline plc
- Stallergenes Greer Ltd
- Hitachi Chemical Co., Ltd
- Omega Diagnostics Group PLC
- bioMérieux SA
- Thermo Fisher Scientific Inc.
- Siemens Healthcare GmbH
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Allergen Type, End Use, Diagnostic Tests, Drug Class, Region |
| Breakup by Product | Instruments, Consumables, Services |
| Breakup by Allergen Type | Food, Inhaled, Drug, Others |
| Breakup by End Use | Diagnostics labs, Hospitals, Academic Research Institutes |
| Breakup by Diagnostic Tests | In-Vivo, Skin Prick Test, Intradermal, Patch Test, In-Vitro |
| Breakup by Drug Class | Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Autoinjectable Epinephrine, Immunotherapy |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Allergy Diagnostics and Therapeutics Market Analysis
8.1 Key Industry Highlights
8.2 Global Allergy Diagnostics and Therapeutics Historical Market (2018-2022)
8.3 Global Allergy Diagnostics and Therapeutics Market Forecast (2023-2028)
8.4 Global Allergy Diagnostics and Therapeutics Market by Product
8.4.1 Instruments
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Consumables
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Services
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.5 Global Allergy Diagnostics and Therapeutics Market by Allergen Type
8.5.1 Food
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Inhaled
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.5.3 Drug
8.5.3.1 Historical Trend (2018-2022)
8.5.3.2 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Allergy Diagnostics and Therapeutics Market by End Use
8.6.1 Diagnostics Labs
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Hospitals
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Academic Research Institutes
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.7 Global Allergy Diagnostics and Therapeutics Market by Diagnostic Tests
8.7.1 In-Vivo
8.7.1.1 Historical Trend (2018-2022)
8.7.1.2 Forecast Trend (2023-2028)
8.7.2 Skin Prick Test
8.7.2.1 Historical Trend (2018-2022)
8.7.2.2 Forecast Trend (2023-2028)
8.7.3 Intradermal
8.7.3.1 Historical Trend (2018-2022)
8.7.3.2 Forecast Trend (2023-2028)
8.7.4 Patch Test
8.7.4.1 Historical Trend (2018-2022)
8.7.4.2 Forecast Trend (2023-2028)
8.7.5 In-Vitro
8.7.5.1 Historical Trend (2018-2022)
8.7.5.2 Forecast Trend (2023-2028)
8.8 Global Allergy Diagnostics and Therapeutics Market by Drug Class
8.8.1 Antihistamines
8.8.1.1 Historical Trend (2018-2022)
8.8.1.2 Forecast Trend (2023-2028)
8.8.2 Decongestants
8.8.2.1 Historical Trend (2018-2022)
8.8.2.2 Forecast Trend (2023-2028)
8.8.3 Corticosteroids
8.8.3.1 Historical Trend (2018-2022)
8.8.3.2 Forecast Trend (2023-2028)
8.8.4 Mast Cell Stabilisers
8.8.4.1 Historical Trend (2018-2022)
8.8.4.2 Forecast Trend (2023-2028)
8.8.5 Leukotriene Inhibitors
8.8.5.1 Historical Trend (2018-2022)
8.8.5.2 Forecast Trend (2023-2028)
8.8.6 Nasal Anticholinergics
8.8.6.1 Historical Trend (2018-2022)
8.8.6.2 Forecast Trend (2023-2028)
8.8.7 Immunomodulators
8.8.7.1 Historical Trend (2018-2022)
8.8.7.2 Forecast Trend (2023-2028)
8.8.8 Autoinjectable Epinephrine
8.8.8.1 Historical Trend (2018-2022)
8.8.8.2 Forecast Trend (2023-2028)
8.8.9 Immunotherapy
8.8.9.1 Historical Trend (2018-2022)
8.8.9.2 Forecast Trend (2023-2028)
8.9 Global Allergy Diagnostics and Therapeutics Market by Region
8.9.1 North America
8.9.1.1 Historical Trend (2018-2022)
8.9.1.2 Forecast Trend (2023-2028)
8.9.2 Europe
8.9.2.1 Historical Trend (2018-2022)
8.9.2.2 Forecast Trend (2023-2028)
8.9.3 Asia Pacific
8.9.3.1 Historical Trend (2018-2022)
8.9.3.2 Forecast Trend (2023-2028)
8.9.4 Latin America
8.9.4.1 Historical Trend (2018-2022)
8.9.4.2 Forecast Trend (2023-2028)
8.9.5 Middle East and Africa
8.9.5.1 Historical Trend (2018-2022)
8.9.5.2 Forecast Trend (2023-2028)
9 North America Allergy Diagnostics and Therapeutics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Allergy Diagnostics and Therapeutics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Allergy Diagnostics and Therapeutics Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.2 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Allergy Diagnostics and Therapeutics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Allergy Diagnostics and Therapeutics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 GlaxoSmithKline plc
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Stallergenes Greer Ltd
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Hitachi Chemical Co., Ltd
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Omega Diagnostics Group PLC
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 bioMérieux SA
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Thermo Fisher Scientific Inc.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Siemens Healthcare GmbH
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Allergy Diagnostics and Therapeutics Market: Key Industry Highlights, 2018 and 2028
2. Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Product (USD Billion), 2018-2022
3. Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Product (USD Billion), 2023-2028
4. Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Allergen Type (USD Billion), 2018-2022
5. Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Allergen Type (USD Billion), 2023-2028
6. Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by End Use (USD Billion), 2018-2022
7. Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by End Use (USD Billion), 2023-2028
8. Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Diagnostic Tests (USD Billion), 2018-2022
9. Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Diagnostic Tests (USD Billion), 2023-2028
10. Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Drug Class (USD Billion), 2018-2022
11. Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Drug Class (USD Billion), 2023-2028
12. Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Region (USD Billion), 2018-2022
13. Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Region (USD Billion), 2023-2028
14. North America Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
15. North America Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Europe Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Europe Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Asia Pacific Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Asia Pacific Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Latin America Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
21. Latin America Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
22. Middle East and Africa Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
23. Middle East and Africa Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
24. Global Allergy Diagnostics and Therapeutics Market Structure
Key Questions Answered in the Report
The global allergy diagnostics and therapeutics market attained a value of nearly USD 38.68 billion in 2022.
The market is projected to grow at a CAGR of 6.50% between 2023 and 2028.
The major drivers of the market include rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, growing investments, and the rising research activities.
The increasing acceptance from the United States for allergy treatment via medical insurance are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The product type in the market includes instruments, consumables, and services.
Allergens can be divided into food, inhaled, and drug, among others. Inhaled allergen is the dominant type of allergy diagnostics and therapeutics in the industry.
End uses can be divided into diagnostics labs, hospitals, and academic research institutes.
In-vivo, skin prick test, intradermal, patch test, and in-vitro are the major diagnostic tests in this industry.
The major players in the industry are GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., and Siemens Healthcare GmbH, among others.
Analyst Review
The global allergy diagnostics and therapeutics market attained a value of USD 38.68 billion in 2022, driven by the rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis. Aided by growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance, the market is expected to witness to further grow at a CAGR of 6.50% in the forecast period of 2023-2028.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The product type in the market includes instruments, consumables, and services. Based on its allergen type, the allergy diagnostics and therapeutics industry can be segmented into food, inhaled, drug, among others, with inhaled allergen accounting for the largest market share. In-vivo, skin prick test, intradermal, patch test, in-vitro are the major diagnostic tests in this industry. End uses can be divided into diagnostics labs, hospitals, and academic research institutes. The major regional markets for allergy diagnostics and therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., and Siemens Healthcare GmbH, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER